Matches in Wikidata for { <http://www.wikidata.org/entity/Q89601123> ?p ?o ?g. }
Showing items 1 to 69 of
69
with 100 items per page.
- Q89601123 description "articolo scientifico (pubblicato il 2020)" @default.
- Q89601123 description "artikull shkencor i botuar më 01 shkurt 2020" @default.
- Q89601123 description "artículu científicu espublizáu en febreru de 2020" @default.
- Q89601123 description "scientific article published on 01 February 2020" @default.
- Q89601123 description "wetenschappelijk artikel" @default.
- Q89601123 description "наукова стаття, опублікована 1 лютого 2020" @default.
- Q89601123 description "գիտական հոդված հրատարակված 2020 թվականի փետրվարի 1-ին" @default.
- Q89601123 name "Correction: The angiogenic inhibitor long pentraxin PTX3 forms an asymmetric octamer with two binding sites for FGF2" @default.
- Q89601123 name "Correction: The angiogenic inhibitor long pentraxin PTX3 forms an asymmetric octamer with two binding sites for FGF2" @default.
- Q89601123 name "Correction: The angiogenic inhibitor long pentraxin PTX3 forms an asymmetric octamer with two binding sites for FGF2" @default.
- Q89601123 type Item @default.
- Q89601123 label "Correction: The angiogenic inhibitor long pentraxin PTX3 forms an asymmetric octamer with two binding sites for FGF2" @default.
- Q89601123 label "Correction: The angiogenic inhibitor long pentraxin PTX3 forms an asymmetric octamer with two binding sites for FGF2" @default.
- Q89601123 label "Correction: The angiogenic inhibitor long pentraxin PTX3 forms an asymmetric octamer with two binding sites for FGF2" @default.
- Q89601123 prefLabel "Correction: The angiogenic inhibitor long pentraxin PTX3 forms an asymmetric octamer with two binding sites for FGF2" @default.
- Q89601123 prefLabel "Correction: The angiogenic inhibitor long pentraxin PTX3 forms an asymmetric octamer with two binding sites for FGF2" @default.
- Q89601123 prefLabel "Correction: The angiogenic inhibitor long pentraxin PTX3 forms an asymmetric octamer with two binding sites for FGF2" @default.
- Q89601123 P1433 Q89601123-2EC4C76C-1E23-485A-B657-9E311034D0B8 @default.
- Q89601123 P1476 Q89601123-3B8812F4-DE86-4B23-BBF5-EB3C3B19743D @default.
- Q89601123 P2093 Q89601123-0E0BE1C4-8874-4007-BE21-B226702E89F2 @default.
- Q89601123 P2093 Q89601123-37AAD66B-EB16-4D1E-B9D6-E63AEE7D56EC @default.
- Q89601123 P2093 Q89601123-4114BA89-4536-48A7-A312-7F3DF57E3FAB @default.
- Q89601123 P2093 Q89601123-520AFBBF-A3B0-4E20-BEE3-79ABFCED4056 @default.
- Q89601123 P2093 Q89601123-5EB4FBDE-C65C-453F-BBCA-82DD8A3F1BCD @default.
- Q89601123 P2093 Q89601123-69ABE9F2-A8A5-4914-9E8C-7930970F726A @default.
- Q89601123 P2093 Q89601123-AE5EFCD3-5A97-4562-85C5-5FB08F9056CD @default.
- Q89601123 P2093 Q89601123-BBCAD8F8-36E3-4617-A8EB-8ED4298BB235 @default.
- Q89601123 P2093 Q89601123-CA6E3413-5F77-4E30-A3C5-28BBA7840D31 @default.
- Q89601123 P2093 Q89601123-E2471920-85CD-44AD-92B8-C69E103B07AA @default.
- Q89601123 P2093 Q89601123-F3693952-6D6A-4238-A6B0-F6E5BE35C8E1 @default.
- Q89601123 P2093 Q89601123-FB714D22-10F6-413C-8E20-A9879A7A0D97 @default.
- Q89601123 P2093 Q89601123-FF1B5DF4-EBDD-4986-97DB-EACDC7E68250 @default.
- Q89601123 P304 Q89601123-54341B23-3D55-4218-92BC-3F8B65F1B508 @default.
- Q89601123 P31 Q89601123-8EF61271-8B21-4489-82FF-AB136A2FEB80 @default.
- Q89601123 P356 Q89601123-C82A90AE-4D94-4283-B769-A26538D868B4 @default.
- Q89601123 P407 Q89601123-8BA1B5A3-FF05-43DD-9A7A-A418C34496A8 @default.
- Q89601123 P433 Q89601123-BCC39FD9-7D2F-4C27-84F3-7FA432FEA0F2 @default.
- Q89601123 P478 Q89601123-667C0144-5229-4FF9-A22B-4EB36E801601 @default.
- Q89601123 P50 Q89601123-682A3D1F-8BA4-4D3E-A3DA-6C3FF0C4607D @default.
- Q89601123 P577 Q89601123-2989DF26-0B28-4A7B-9922-BD28ABB56B34 @default.
- Q89601123 P698 Q89601123-1FBEF9A3-253F-4C9D-9E94-03D394D84F4C @default.
- Q89601123 P932 Q89601123-4CCA7F32-1A9A-418D-A6E1-A10BD5493C9C @default.
- Q89601123 P356 JBC.AAC120.012568 @default.
- Q89601123 P698 32034013 @default.
- Q89601123 P1433 Q867727 @default.
- Q89601123 P1476 "Correction: The angiogenic inhibitor long pentraxin PTX3 forms an asymmetric octamer with two binding sites for FGF2" @default.
- Q89601123 P2093 "Anthony J Day" @default.
- Q89601123 P2093 "Antonio Inforzato" @default.
- Q89601123 P2093 "Antonio Verdoliva" @default.
- Q89601123 P2093 "Barbara Bottazzi" @default.
- Q89601123 P2093 "Clair Baldock" @default.
- Q89601123 P2093 "David C Briggs" @default.
- Q89601123 P2093 "David F Holmes" @default.
- Q89601123 P2093 "Giovanni Salvatori" @default.
- Q89601123 P2093 "Karl E Kadler" @default.
- Q89601123 P2093 "Marcella Marcellini" @default.
- Q89601123 P2093 "Ragnar Lindstedt" @default.
- Q89601123 P2093 "Thomas A Jowitt" @default.
- Q89601123 P2093 "Vincenzo Rivieccio" @default.
- Q89601123 P304 "1768" @default.
- Q89601123 P31 Q13442814 @default.
- Q89601123 P356 "10.1074/JBC.AAC120.012568" @default.
- Q89601123 P407 Q1860 @default.
- Q89601123 P433 "6" @default.
- Q89601123 P478 "295" @default.
- Q89601123 P50 Q22069468 @default.
- Q89601123 P577 "2020-02-01T00:00:00Z" @default.
- Q89601123 P698 "32034013" @default.
- Q89601123 P932 "7008370" @default.